Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BME/FAE stock hub

BME/FAE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BME/FAEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

Madrid Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BME/FAE

In the news

Latest news · BME/FAE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.1

P25 n/aP50 n/aP75 n/a

Trailing P/E18.3

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC8.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BME/FAE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

EUR

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	ES
Employees	2,681
Employees Change	905%
Employees Change Percent	50.96
Enterprise value	EUR 1.8B
Exchange	Madrid Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	ES0134950F36
Last refreshed	2026-05-10
Market cap	EUR 1.5B
Price	EUR 4.82
Price currency	EUR
Rev Per Employee	251,608.44x
Sector	Healthcare
Sic	2834
Symbol	bme/FAE
Website	https://faesfarma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.47%
EV Earnings	21.97x
EV/EBIT	19.24x
EV/EBITDA	14.62x
EV/Sales	2.67x
Forward P/E	15.08x
P/B ratio	2.01x
P/E ratio	18.29x
P/S ratio	2.22x
PE Ratio10 Y	15.54x
PE Ratio3 Y	12.62x
PE Ratio5 Y	12.57x
PEG ratio	1.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.9%
EBITDA Margin	17.63%
Gross margin	64.39%
Gross Profit	EUR 434.1M
Gross Profit Growth	26.44%
Gross Profit Growth Q	32.65%
Gross Profit Growth3 Y	12.28%
Gross Profit Growth5 Y	11.1%
Net Income	EUR 82M
Net Income Growth	-24.92%
Net Income Growth Q	8.49%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-3.24%
Net Income Growth5 Y	2.31%
Pretax Margin	13.04%
Profit Margin	12.17%
Profit Per Employee	EUR 30,623
Profitable Years	23
Roa5y	8.22
Roe5y	14.66
ROIC	8.35
Roic5y	15.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.37%
Cagr15y	8.36%
Cagr1y	17.45%
Cagr20y	2.17%
Cagr3y	16.03%
Cagr5y	10.53%
Div CAGR10	3.47%
Div CAGR3	-11.18%
Div CAGR5	-8.26%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	28.63x
Revenue Growth Q	30.77x
Revenue Growth Quarters	8x
Revenue Growth Years	13x
Revenue Growth3 Y	13.04x
Revenue Growth5 Y	11.35x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	EUR 130.1M
Debt	EUR 433.3M
Debt EBITDA	EUR 3.51
Debt Equity	EUR 0.58
Equity	EUR 745.6M
Interest Coverage	13.8
Net Cash	EUR -303.2M
Net Cash By Market Cap	EUR -20.23
Net Debt EBITDA	EUR 2.55
Net Debt Equity	EUR 0.41
Tangible Book Value	EUR 308M
Tangible Book Value Per Share	EUR 0.99
WACC	5.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-28.49%
Dividend Growth Years	1%
Dividend per share	EUR 0.18
Dividend Years	38
Dividend Yield	3.72%
Ex Div Date	2026-06-23
Last Dividend	EUR 0.07
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	144.78%
1Y total return	17.44%
200-day SMA	4.68
3Y total return	56.21%
50-day SMA	4.76
50-day SMA vs 200-day SMA	50over200
5Y total return	64.93%
All Time High	11.58
All Time High Change	-58.42%
All Time High Date	2007-04-11
All Time Low	0.47
All Time Low Change	917.76%
All Time Low Date	1992-09-22
ATR	0.09
Beta	0.34
Beta1y	0.82
Beta2y	0.62
Ch YTD	-6.69
High	4.87
High52	5.44
High52 Date	2026-01-07
High52ch	-11.49%
Low	4.82
Low52	4.1
Low52 Date	2025-09-02
Low52ch	17.44%
Ma50ch	1.24%
Price vs 200-day SMA	2.93%
RSI	49.04
RSI Monthly	60.86
RSI Weekly	51.11
Sharpe ratio	0.75x
Sortino ratio	1.43
Total Return	3.72%
Tr YTD	-6.11
Tr15y	233.47%
Tr1m	3.22%
Tr1w	-1.23%
Tr3m	-7.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 93.7M
Operating Income Growth	-12.52
Operating Income Growth Q	14.53
Operating Income Growth3 Y	-3.07
Operating Income Growth5 Y	0.28
Operating margin	13.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	229,077,296%
Shares Insiders	2.27%
Shares Institutions	9.5%
Shares Out	311,261,239
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	121,810.5x
Bv Per Share	2.39
Ch10y	74.46
Ch15y	109.7
Ch1m	3.22
Ch1w	-1.23
Ch1y	13.83
Ch20y	-10.39
Ch3m	-7.23
Ch3y	44.6
Ch5y	37.89
Ch6m	9.56
Change	-0.93%
Change From Open	-1.13
Close	4.86
Days Gap	0.21
Depreciation Amortization	25,157,250
Dollar Volume	406,751.9
Earnings Date	2026-04-30
EBIT	EUR 93.7M
EBITDA	EUR 118.8M
EPS	EUR 0.26
F Score	1
Fiscal Year End	December
Founded	1,933
Graham Number	3.76447
Graham Upside	-21.82
Income Tax	EUR 5.8M
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2015-04-07
Last Split Type	Forward
Lynch Fair Value	EUR 1.32
Lynch Upside	-72.67
Ma150	4.82
Ma150ch	-0.1%
Ma20	4.87
Ma20ch	-1.09%
Next Earnings Date	2026-07-27
Open	4.87
Payment Date	2026-06-25
Position In Range	0
Price Date	2026-05-08
Price EBITDA	EUR 12.61
Ptbv Ratio	4.87
Relative Volume	0.7x
Revenue	674,059,000x
Tax By Revenue	0.85x
Tax Rate	6.56%
Tr20y	53.64%
Tr6m	10.24%
Volume	84,476

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BME/FAE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.7%

$0.18 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-8.3%

1 consecutive years of growth

Total shareholder yield

+3.7%

Next ex-dividend date: 2026-06-23

Performance

BME/FAE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BME/FAE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.5%

Share of float held by funds and institutions

Insider ownership

+2.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

BME/FAE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.0

Neutral momentum band

Price vs 200-day MA

+2.9%

50/200-day relationship not available

Beta (5Y)

0.34

Less volatile than the market

Sharpe ratio

0.75

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BME/FAE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bme/FAE stock rating?

bme/FAE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bme/FAE analysis?

The full report lives at /stocks/bme/FAE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bme/FAE?

The latest report frames bme/FAE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bme/FAE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.